Skip to main content
Follow Gene Therapy Net on X LinkedIn - Gene Therapy Net discussion group Facebook - Gene Therapy Net
 
Gene Therapy Net Newsletter  
genetherapynetbanner468x60

News: FDA Needs More Cell, Gene Therapy Mid Managers to Speed Reviews

The FDA is struggling to hire mid-level managers in cell and gene therapies as the agency looks to fill more than 100 slots in this burgeoning field and remedy slow responses to drugmakers. 

Read more…

­

News: Biology Professor Venigalla Rao Makes Breakthrough on Gene Therapy Research

A new gene therapy technology being developed on campus could open the doors to healing and curing a variety of ailments, according to new research by Biology Professor Venigalla Rao published May 30 in the international scientific journal Nature Communications. Rao is the founding director of The Catholic University of America’s Bacteriophage Medical Research Center devoted to researching the therapeutic potential of a type of virus called bacteriophage T4 that grows on E.coli bacteria that cannot infect humans and many of which are part of a healthy body’s microbiome. 

Read more…

­

Conference: In Vivo Engineering of Cell Therapies Summit

The 2nd In Vivo Engineering of Therapeutic Cells Summit (July 10-12 2023) is your ultimate guide to exploring the latest innovations in R&D, navigating the murky regulatory landscape, gaining new insights on the safety concerns of genome editing/integration, and unpacking key manufacturing/CMC challenges to develop quality, scalable processes.

Register now…

­

Conference: 4th RNA Editing Summit

The 4th RNA Editing Summit (July 11 -13) is the world-leading industry-dedicated conference that brings together strategic and technical experts sharing case studies with actionable insight spanning the latest advancements in the RNA editing field to progress from early discovery through to translation into the clinic.

Register now…

­

Conference: 4th Gamma Delta T Therapies Summit

Gamma Delta T cells prove an exciting technology for the treatment of solid tumor indications and beyond, the unique features of these cells are revolutionizing the development of allogeneic therapies. As industry leaders supercharge their development; the race to demonstrate clinical efficacy is upon us, with data read outs from IN8bio, Adicet Bio, and Imcheck therapeutics to name a few.
The hotly anticipated 4th Annual Gamma Delta T Therapies Summit (July 25-27) returns to bring clinical and commercial Gamma Delta T Therapies to patients in need. As Gamma Delta T Therapeutics continue to showcase advancements, join the experts in this field to better characterize gamma delta subsets, drive efficacy through informed mechanisms of action and supercharge the homing, targeting and immune surveillance for better, safer and more efficacious gamma delta therapeutics.
Dedicated to enhancing expansion strategies, engineering to ensure efficacy, specificity and persistence the 4th Annual Gamma Delta T Therapies Summit is your one stop shop to accelerating Gamma Delta Therapeutics to the clinic.

Register now…

­

Conference: Bioprocessing Summit 2023

Celebrating its fifteenth year, The Bioprocessing Summit, August 14-17, 2023 in Boston, is a premier global forum for industry leaders to share the latest developments in bioprocess R&D, scale-up, quality and analytics. This year's programming comprises more in-depth content than ever before, showcasing 8 topic-focused streams, 14 conference tracks, interactive sessions, panel discussions, training seminars, research posters, and so much more.  Learn from over 300 top researchers and network with more than 1,500 global participants.  View the agenda and register today at BioprocessingSummit.com 

Register now…

­

Conference: mRNA Analytical Development Summit Europe 

Uniting technical mRNA specialists in Europe for the very first time, the inaugural mRNA Analytical Development Summit Europe will bring 80+ Analytical Development, CMC, Quality, and Regulatory experts to Berlin this August (29th - 31st August). Highlighting the importance of advanced analytical approaches and adherence to regulatory requirements, this meeting is the only industry-dedicated forum to showcase critical expertise and the latest techniques in optimised analytics for leading European biopharma.
Hear from 19+ European thought leaders across 3 days and 2 workshops of immersive content, with speakers confirmed from AstraZeneca, Ziphius Vaccines, BioNTech, Moderna, GSK, VaxEquity, Novartis and more. This meeting will enable you to confidently identify and quantify critical quality attributes through advanced analytical platforms to guarantee the quality, efficacy and safety of your mRNA therapeutics and vaccines, safeguarding your regulatory submissions in 2023 and beyond.

Register now…

­

Conference: 3rd Inner Ear Disorders Therapeutics Summit 

Are you looking to collectively accelerate the advancement of Hearing Disorder Therapeutics?

Join the 3rd Inner Ear Disorders Therapeutics Summit (August 29-31) to:

▪ Explore how to improve clinical trial design to achieve regulatory approval

▪ Delve into the numerous delivery methods being employed in the industry

▪ Evaluate the current opportunities and limitations of using animal models

▪ Leverage valuable insights from VC investors

▪ Navigate the complex landscape of improving the diagnostics of inner ear disorders

View the full event guide to learn more.

Register now…

­

Conference: 8th CAR-TCR Summit

The 8th CAR-TCR Summit (August 29 – September 1) is returning to Boston as the industry’s trusted, definitive, end-to-end forum for the global network of autologous and allogeneic cell therapy drug developers. Ensure your whole team stays ahead of the curve with unmatched industry insights shared across discovery through to commercialization.  
Across 3 conference days with 8 content tracks, and an additional 6 deep-dive workshops, bootcamp, focus day, diversity session, C-level think tank and more, 200+ CAR and TCR experts will lead you and over 1,000 peers in discussions that will accelerate your pipeline, bringing better drugs to patients faster. 
View the full agenda now to find out more!

Register now…

­

Conference: Viral Vector Formulation & Process Development Summit Europe 

The Viral Vector Formulation & Process Development Summit (30th-31st August) is the only definitive, end-to-end platform, uniting 60+ experts across up-and downstream process development, formulation, analytical development and regulatory disciplines from biopharma. Across 2 days, hear from 18 viral vector pioneers working in cell and gene therapy and vaccine development, including Roche, VectorY, UCB, DiNAQOR and AviadoBio to share their lessons learned and inspirations to overcome bottlenecks during scale-up and to reduce COGs

Register now…

­

Upcoming conferences and meetings

  • 20 – 21 June 2023 - 3rd Gene and Cell Therapies: CMC, CGT & Vector Manufacturing Summit - Vienna, Austria
  • 20 – 22 June 2023 - Next Gen Inhalation Delivery Summit - Boston, MA
  • 21 – 22 June 2023 - 6th Aseptic Processing Summit - Manufacturing processes for ATMPs and vaccines - Vienna
  • 26 - 29 June 2023 - Gene Therapy & Rare Diseases conference - Boston, MA
  • 27 - 29 June 2023 - Next Generation Gene Therapy Vectors Summit - Boston, MA
  • 10 - 12 July 2023 - In Vivo Engineering of Cell Therapies Summit - Boston, MA
  • 11 - 13 July 2023 - 4th RNA Editing Summit - Boston, MA
  • 11 - 13 July 2023 - 2nd Annual Optimizing AAV Safety Summit - Boston, MA
  • 18 - 20 July 2023 - 3rd Tumor Myeloid-Directed Therapies Summit - Boston, MA
  • 25 - 27 July 2023 - 4th Gamma Delta T Therapies Summit - Boston, MA
  • 26 - 28 July 2023 - 3rd Annual mRNA-Based Therapeutics Summit - Boston, MA
  • 9 August 2023 - Drug Discovery and Development - Cell & Gene Therapies - London, UK
  • 14 - 17 August 2023 - The Bioprocessing Summit 2023 - Boston, MA
  • 29 - 31 August 2023 - 3rd Inner Ear Disorders Therapeutics Summit - Gene & Cell Therapies - Boston, MA
  • 29 - 31 August 2023 - mRNA Analytical Development Summit Europe - Berlin, Germany
  • 29 - 31 August 2023 - Gene Therapy Potency Summit - Boston, MA
  • 29 August - 1 September 2023 - 8th CAR-TCR Summit - Boston, MA
  • 30 - 31 August 2023 - Viral Vector Formulation & Process Development Summit Europe - Amsterdam, Netherlands
  • 5 - 7 September 2023 - 4th Annual Gene Therapy Immunogenicity Summit - Boston, MA
  • 5 - 7 September 2023 - 5th Exosome Based Therapeutic Development Summit - Gene Therapies - Boston, MA
  • 6 - 7 September 2023 - RNA Leaders USA Congress - Boston, MA
  • 12 - 14 September 2023 - 3rd Annual Mitochondria-Related Drug Development Summit - Gene Therapies - Boston, MA
  • 18 - 21 September 2023 - Cell & Gene Therapy Manufacturing & Commercialization US - Boston, MA
  • 18 - 21 September 2023 - BioProcess International - ATMP - Boston, MA
  • 19 - 21 September 2023 - 2nd Cell Therapy Analytical Development Europe - Amsterdam, The Netherlands
  • 27 - 29 September 2023 - Smart Bioprocessing & Pharma 4.0 Summit - Cell & Gene Therapies - Berlin, Germany
  • 18 – 19 October 2023 - World Drug Safety Congress Americas 2023 - Boston, MA
  • 24 – 27 October 2023 - Annual Congress of the European Society of Gene and Cell Therapy - Brussels, Belgium
  • 31 October - 2 November 2023 - 14th World Orphan Drug Congress Europe - Barcelona, Spain
  • 6 - 9 November 2023 - 5th Gene Therapy for Neurological Disorders Summit - Boston, MA
  • 7 - 8 November 2023 - Cell Series UK 2023 - London, UK
  • 4 – 7 December 2023 - Cell & Gene Therapy Manufacturing & Commercialization Europe - Dublin, Ireland

Advertise on this site?